Indiana University Simon Comprehensive Cancer Center

Indianapolis, Indiana 46202

4 studies enrolling now · 10 studies all time

What they study most

Advanced Breast Cancer, Advanced Lung Cancer, Advanced Renal Cell Carcinoma, B-cell Lymphoma, Breast Cancer, Breast Carcinoma, Burkitt Lymphoma, Clear Cell, Clear Cell Renal Cell Carcinoma, DLBCL, Endometrioid Ovarian Cancer, Fallopian Tube Cancer

Studies at this site

• Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) — Recruiting now
• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — Recruiting now
• Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer — Recruiting now
• NearWave Optical Molecular Monitoring — Recruiting now
• ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies — Completed
• Pembrolizumab Plus Olaparib in LA-HNSCC — Running, not enrolling
• A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma — Stopped early
• A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation — Stopped early
• Telephone Support for Metastatic Breast Cancer Patients — Completed
• Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers — Completed